Regulation 291 Form and content of advertisement

United Kingdom

(1)

A person may not publish an advertisement relating to a medicinal product unless it is presented so that—

(a)

it is clear that it is an advertisement; and

(b)

the product is clearly identified as a medicinal product.

(2)

A person may not publish an advertisement relating to a medicinal product unless it includes—

(a)

the name of the medicinal product;

(b)

if the medicinal product contains only one active ingredient, the common name of the active ingredient;

(c)

the information necessary for the correct use of the medicinal product; and

(d)

an express and clear invitation to read carefully the instructions on the package or in the package leaflet (as the case may be).

(3)

This regulation is subject to regulation 296 (exception for advertisements intended as a reminder).

(4)

Paragraph (2) is subject to regulation 301 (advertisements for registered homoeopathic medicinal products).

F1(5)

Paragraph (2)(d) is subject to regulation 291A (campaigns relating to the suspected or confirmed spread of pathogenic agents etc.).

Annotations

F1: Reg. 291(5) inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 23 and reg. 291(5) inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 23